| Professional Services Industry | Industrials Sector | Mr. Mikael Havsjo CEO | XSTO Exchange | - ISIN |
| SE Country | 13 Employees | - Last Dividend | - Last Split | - IPO Date |
Level Bio AB (publ), initially known as AlphaHelix Molecular Diagnostics AB, stands as a formidable entity in the design, development, and distribution of diagnostic products, reaching the Nordic region and beyond. Since its inception in 1998 and subsequent rebranding in May 2024, the company has established its headquarters in Stockholm, Sweden. It focuses on an array of diagnostics areas including genetic fetal diagnostics, genetic miscarriage, infertility diagnostics products, and the development of products targeting congenital heart defect. By catering to the Nordic region, specifically Sweden, and other international markets, Level Bio AB (publ) ensures the provision of top-tier equipment, consumables, reagents for molecular biology, and both research and diagnostic products.